P Kocea1,2, K Mischke2, H-P Volk1, U Eberle1, J R Ortlepp3,4. 1. Klinik für Innere Medizin und Intensivmedizin, Asklepios Kliniken Schildautal, Karl-Herold-Straße 1, 38723, Seesen, Deutschland. 2. Medizinische Klinik I, Universitätsklinikum Aachen, RWTH Aachen, Aachen, Deutschland. 3. Klinik für Innere Medizin und Intensivmedizin, Asklepios Kliniken Schildautal, Karl-Herold-Straße 1, 38723, Seesen, Deutschland. j.ortlepp@asklepios.com. 4. Medizinische Klinik I, Universitätsklinikum Aachen, RWTH Aachen, Aachen, Deutschland. j.ortlepp@asklepios.com.
Abstract
BACKGROUND: Patients with pulmonary embolism (PE) have heterogeneous symptoms. Clinical scores and age-adjusted D‑dimer should help clinicians to establish the correct diagnosis. METHODS: A cohort of 1,943 consecutive patients with positive D‑dimer levels who were referred for CT pulmonary angiography (CTPA) over a period of 5 years to rule PE in or out were retrospectively analyzed. RESULTS: On CTPA n = 362 (19 %) had PE. The prevalence of PE increased stepwise with increasing D‑dimer levels (prevalence of PE with 10 percentiles of D‑dimers was: 3 %, 4 %, 7 %, 8 %, 8 %, 21 %, 20 %, 27 %, 37 %, 52 %; p < 0.001). D‑dimers > 2.0 were significantly associated with PE (OR 7.17 95 % CI 5.27-9.76, p < 0.001). Chest discomfort and tachypnea showed no association with PE. Dyspnoea, pleuritic pain, and general fatigue showed significant associations with age: pleuritic chest pain was more frequent in patients aged < 76 years than in patients aged > 76 years (15 % vs 3 %; p < 0.001) and was highly significantly associated with PE (OR 4.99 95 % CI 2.83-8.81; p < 0.001). General fatigue was more prevalent in patients aged > 76 years (44 % vs 24 %; p < 0.001). PE patients with D‑dimers > 6.0 mg/l were hemodynamically more compromised than patients with D‑dimers < 6.0 mg/l: tachycardia 32 % vs 20 %, p = 0.015; right ventricular strain on echocardiography: 38 % vs 23 %, p = 0.003; right ventricular strain on ECG: 27 % vs 13 %; p = 0.001; resuscitation 4 % vs 0 %, p = 0.003; lytic therapy 6 % vs 1 %, p = 0.014. CONCLUSION: The symptoms of PE patients are often vague. Particularly in older patients, fatigue may be the only symptom. The absolute level of D‑dimers, particularly > 2.0 mg/l, is a strong predictor of PE. A D‑dimer level > 6.0 mg/l is associated with more severe hemodynamic impairment in patients with PE.
BACKGROUND:Patients with pulmonary embolism (PE) have heterogeneous symptoms. Clinical scores and age-adjusted D‑dimer should help clinicians to establish the correct diagnosis. METHODS: A cohort of 1,943 consecutive patients with positive D‑dimer levels who were referred for CT pulmonary angiography (CTPA) over a period of 5 years to rule PE in or out were retrospectively analyzed. RESULTS: On CTPA n = 362 (19 %) had PE. The prevalence of PE increased stepwise with increasing D‑dimer levels (prevalence of PE with 10 percentiles of D‑dimers was: 3 %, 4 %, 7 %, 8 %, 8 %, 21 %, 20 %, 27 %, 37 %, 52 %; p < 0.001). D‑dimers > 2.0 were significantly associated with PE (OR 7.17 95 % CI 5.27-9.76, p < 0.001). Chest discomfort and tachypnea showed no association with PE. Dyspnoea, pleuritic pain, and general fatigue showed significant associations with age: pleuritic chest pain was more frequent in patients aged < 76 years than in patients aged > 76 years (15 % vs 3 %; p < 0.001) and was highly significantly associated with PE (OR 4.99 95 % CI 2.83-8.81; p < 0.001). General fatigue was more prevalent in patients aged > 76 years (44 % vs 24 %; p < 0.001). PE patients with D‑dimers > 6.0 mg/l were hemodynamically more compromised than patients with D‑dimers < 6.0 mg/l: tachycardia 32 % vs 20 %, p = 0.015; right ventricular strain on echocardiography: 38 % vs 23 %, p = 0.003; right ventricular strain on ECG: 27 % vs 13 %; p = 0.001; resuscitation 4 % vs 0 %, p = 0.003; lytic therapy 6 % vs 1 %, p = 0.014. CONCLUSION: The symptoms of PE patients are often vague. Particularly in older patients, fatigue may be the only symptom. The absolute level of D‑dimers, particularly > 2.0 mg/l, is a strong predictor of PE. A D‑dimer level > 6.0 mg/l is associated with more severe hemodynamic impairment in patients with PE.
Authors: Frederick Palm; Christian Urbanek; Steffen Rose; Florian Buggle; Barbara Bode; Michael G Hennerici; Kirsten Schmieder; Gerhard Inselmann; Rainer Reiter; Robert Fleischer; Karl-Otto Piplack; Anton Safer; Heiko Becher; Armin J Grau Journal: Stroke Date: 2010-08-05 Impact factor: 7.914
Authors: E Ceriani; C Combescure; G Le Gal; M Nendaz; T Perneger; H Bounameaux; A Perrier; M Righini Journal: J Thromb Haemost Date: 2010-02-02 Impact factor: 5.824
Authors: John A Heit; Catie E Kobbervig; Andra H James; Tanya M Petterson; Kent R Bailey; L Joseph Melton Journal: Ann Intern Med Date: 2005-11-15 Impact factor: 25.391
Authors: Arne van Belle; Harry R Büller; Menno V Huisman; Peter M Huisman; Karin Kaasjager; Pieter W Kamphuisen; Mark H H Kramer; Marieke J H A Kruip; Johanna M Kwakkel-van Erp; Frank W G Leebeek; Mathilde Nijkeuter; Martin H Prins; Maaike Sohne; Lidwine W Tick Journal: JAMA Date: 2006-01-11 Impact factor: 56.272
Authors: L W Tick; M Nijkeuter; M H H Kramer; M M C Hovens; H R Büller; F W G Leebeek; M V Huisman Journal: J Intern Med Date: 2008-04-29 Impact factor: 8.989
Authors: Grégoire Le Gal; Marc Righini; Pierre-Marie Roy; Olivier Sanchez; Drahomir Aujesky; Henri Bounameaux; Arnaud Perrier Journal: Ann Intern Med Date: 2006-02-07 Impact factor: 25.391
Authors: Alexander T Cohen; Giancarlo Agnelli; Frederick A Anderson; Juan I Arcelus; David Bergqvist; Josef G Brecht; Ian A Greer; John A Heit; Julia L Hutchinson; Ajay K Kakkar; Dominique Mottier; Emmanuel Oger; Meyer-Michel Samama; Michael Spannagl Journal: Thromb Haemost Date: 2007-10 Impact factor: 5.249